Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
dF0U3nRZnEMxSSYL